BMP-2 vs OGP
Head-to-head comparison of BMP-2 (Recombinant Human Bone Morphogenetic Protein-2) and OGP (Osteogenic Growth Peptide) — benefits, dosing, side effects, research data, and where to buy.
| Property | BMP-2 | OGP |
|---|---|---|
| Category | Recovery & Healing | Recovery & Healing |
| Full Name | Recombinant Human Bone Morphogenetic Protein-2 | Osteogenic Growth Peptide |
| Molecular Weight | 26000 Da | 1600 Da |
| Half-Life | short, localized exposure | N/A |
| Amino Acids | 114 | 14 |
| Typical Dose | 1.5 mg/mL local implant | research-dependent low microgram range |
| Route | Local/Implant | Subcutaneous/Local |
| Purity | ≥98% | ≥98% |
| Studies Count | 1500 | 80 |
| Research Status | Clinical | Pre-clinical |
BMP-2 Benefits
- ✓promotes osteogenesis
- ✓supports nonunion healing
- ✓enhances scaffold-based repair
- ✓may improve defect fill
OGP Benefits
- ✓stimulates osteoblast activity
- ✓supports fracture repair
- ✓may increase bone matrix deposition
- ✓may improve healing after injury
BMP-2 Dosing
local implantation on collagen sponge|single intraoperative dose|procedure-specific scaffold delivery
OGP Dosing
research-dependent microgram or nanomolar dosing|subcutaneous or local experimental delivery|cycle-dependent in studies
BMP-2 Side Effects
- ⚠local inflammation
- ⚠ectopic bone formation
- ⚠edema
OGP Side Effects
- ⚠uncertain safety profile
- ⚠injection-site irritation
- ⚠theoretical endocrine effects
Research Overview
BMP-2
rhBMP-2 has strong clinical and translational literature for bone regeneration, spinal fusion, and defect repair. Its use is primarily local because systemic exposure is not the intended mechanism.
OGP
OGP has mostly preclinical literature showing effects on bone cell signaling, mineralization, and repair models. It is not as clinically established as teriparatide or BMPs, but it is a genuine peptide in the bone-regeneration literature.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.